Gary Middleton

Colleges, School and Institutes

View graph of relations

Most downloaded publications

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
Gary Middleton, 4 Feb 2016, In : British Journal of Cancer.

Research output: Contribution to journal › Article › peer-review

656 downloads
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
& 31 others, , Gary Middleton, 25 May 2017, In : Nature. 545, 7655, p. 446-451 6 p.

Research output: Contribution to journal › Article › peer-review

535 downloads
Tracking the Evolution of Non-Small-Cell Lung Cancer
& 63 others, , Babu Naidu, Gary Middleton, 1 Jun 2017, In : New England Journal of Medicine. 376, 22, p. 2109-2121

Research output: Contribution to journal › Article › peer-review

430 downloads
An immunogenomic stratification of colorectal cancer : implications for development of targeted immunotherapy
Andrew Beggs, Benjamin Willcox & Gary Middleton, 2 Apr 2015, In : OncoImmunology. 4, 3, e976052.

Research output: Contribution to journal › Article › peer-review

312 downloads
The National Lung Matrix Trial : translating the biology of stratification in advanced non-small-cell lung cancer
Gary Middleton & Lucinda Billingham, 12 Dec 2015, In : Annals of Oncology. 26, 12, p. 2464-2469

Research output: Contribution to journal › Article › peer-review

194 downloads

Recent publications

Utility of COVID-19 screening in cancer patients
14 Sep 2020, In : Cancer Cell. 38, 3, p. 306-307 2 p.

Research output: Contribution to journal › Letter › peer-review

Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer
Gary Middleton, Amanda Farley & 7 others, & Lucinda Billingham, 5 Sep 2020, In : Nature.

Research output: Contribution to journal › Article

Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?
Oliver Pickles, Lennard Lee & Gary Middleton, Sep 2020, In : British Journal of Cancer. 123, 5, p. 691-693 3 p.

Research output: Contribution to journal › Article › peer-review

View all (75)

Recent Activities

A Phase II Clinical Trial with Efficacy and Toxicity Outcomes and Baseline Covariates

Kristian Brock (Speaker), Lucinda Billingham (Contributor), Gary Middleton (Contributor) & Christina Yap (Contributor)

2 Jul 2018

Activity: Talk or presentation › Academic conference

Design dilemmas in the multi-drug, genetic-marker-directed, non-comparative, multi-centre, multi-arm phase II National Lung Matrix Trial

Lucinda Billingham (Invited speaker), (Invited speaker), Kristian Brock (Invited speaker), (Invited speaker) & Gary Middleton (Invited speaker)

26 Aug 2014

Activity: Talk or presentation › Academic conference

View all (2)